KOSDAQOthers339950

Ibkimyoung

₩2,215 0.00%2026-11-18 close
Market Cap
₩99.6B
Turnover
₩70,102,528
Volume
30K
Shares out.
45M
PER
6.0×
PBR
1.5×
EPS
₩369
Dividend Yield
13.57%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩300 per share · Prices as of the 2026-11-18 close

01

Report overview

Admissions Core Plus Beauty: Margin Recovery in Progress

Ibkimyoung's sales and operating profit have risen for three consecutive years from 2023 through 2025 on the back of its university transfer admissions business, while beauty growth and a smaller loss in other businesses in 2026 coexist with sharp swings in quarterly profit.

  1. 1

    Sales reached KRW 119.5 billion in 2025 and operating profit KRW 19.1 billion. Operating margin climbed from 3.6% in 2022 to 16.0% in 2025.

  2. 2

    A Korea IR Council estimate puts 2026 transfer admissions revenue at KRW 85.2 billion and beauty vocational education revenue at KRW 23.2 billion. Both figures are estimates rather than company disclosures.

  3. 3

    Operating profit in the third quarter of 2026 was KRW 9.39 billion, up 207.0% from the prior quarter but down 3.5% year on year. The first quarter of 2026, at KRW 347 million, was the low point.

  4. 4

    The company set a target of keeping its shareholder return ratio at 25% or higher from 2026 and planned a KRW 13.0 billion dividend for fiscal 2025.

  5. 5

    The other businesses segment posted an operating loss of KRW 190 million in the first half of 2026, narrowed from KRW 770 million a year earlier.

02

Business structure

Ibkimyoung's business runs on three pillars: transfer admissions education, beauty vocational education, and other businesses.

Transfer admissions is built around the Kimyoung Pyeonip brand, which offers university transfer lectures, online courses and study materials, and News1 reported in June 2026 that the brand holds the number one share of the university transfer market.

News1 also reported that transfer education revenue was KRW 81.1 billion in 2025. A 2024 LS Securities report put the revenue mix at roughly 75% admissions and 25% vocational education, a snapshot from 2024 that may differ from the current mix.

Within beauty, the Megastudy Beauty Academy and MBC Academy Beauty brands run courses in makeup, hair, nails and esthetics, covering everything from beauty-program admissions to certification and job or startup placement.

In its third-quarter 2025 results release, the company said the effect of its acquisition of Beauruscha was now fully reflected in beauty education.

Other businesses include adult job-training courses such as computer design, IT development and national technical certifications, along with lifelong education and publishing. First-half 2026 revenue in this segment was KRW 9.85 billion, down from KRW 11.32 billion a year earlier.

Same-industry listed peers include MegaStudyEdu and Daekyo, but their segment mix differs, which limits direct comparison. News1 cited the question of whether growth in vocational education revenue translates into real company profit as a risk factor.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩36B₩9.7B27.1%
2025Q4₩33.2B₩6B18.0%
2026Q1₩24.2B₩300M1.4%
2026Q2₩28.3B₩3.1B10.8%
2026Q3₩37.5B₩9.4B25.1%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩86.5B₩3.1B₩300M3.6%0.7%112.1%
2023₩94.7B₩8.9B₩7.8B9.4%17.4%90.9%
2024₩107.1B₩16.5B₩12.7B15.4%23.1%86.2%
2025₩119.5B₩19.1B₩20.7B16.0%28.1%70.4%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

On the disclosed annual figures, sales rose from KRW 86.5 billion in 2022 to KRW 119.5 billion in 2025, with growth of 9.5% in 2023 to KRW 94.7 billion, 13.1% in 2024 to KRW 107.1 billion, and 11.6% in 2025, marking three consecutive years of increases from 2023 through 2025.

Operating profit went from KRW 3.08 billion in 2022 to KRW 8.94 billion in 2023 (up 189.9%), KRW 16.5 billion in 2024 (up 84.5%) and KRW 19.1 billion in 2025 (up 15.6%). Operating margin rose from 3.6% in 2022 to 9.4%, 15.4% and 16.0% in 2025, so margin expansion outpaced sales growth.

Profit attributable to controlling shareholders grew from KRW 261 million in 2022 to KRW 7.77 billion, KRW 12.7 billion and KRW 20.7 billion, with 2025 the largest year of the four.

Net profit including non-controlling interests moved from a net loss of KRW 22.8 billion in 2022 to a profit of KRW 6.65 billion in 2023 and KRW 20.1 billion in 2025.

The debt ratio fell from 112.1% in 2022 to 70.4% in 2025, with total equity at KRW 70.9 billion and total liabilities at KRW 49.9 billion at year-end 2025. Operating cash flow rose from KRW 14.6 billion in 2022 to KRW 32.8 billion in 2025.

Quarterly, operating profit fell from KRW 9.73 billion in the third quarter of 2025 to KRW 5.97 billion in the fourth quarter (down 38.7% from the prior quarter) as sales dropped 7.7% to KRW 33.2 billion.

The first quarter of 2026 was the low point, with sales of KRW 24.2 billion (down 27.1% from the prior quarter) and operating profit of KRW 347 million. The company said on May 14, 2026 that operating profit and net profit both turned positive year on year in that seasonally weak quarter.

Operating profit recovered to KRW 3.06 billion in the second quarter. In the third quarter, sales reached KRW 37.5 billion (up 4.2% year on year), operating profit KRW 9.39 billion (down 3.5% year on year), and profit attributable to controlling shareholders KRW 7.68 billion (down 6.8% year on year). Profit attributable to controlling shareholders over the latest four quarters totaled KRW 16 billion.

05

Industry analysis

Demand in the university transfer market is driven by admissions quotas at top domestic universities. In a 2024 report, LS Securities said transfer admission places at the top 15 domestic universities rose 17.7% year on year to 3,416, and places at universities in the Seoul metropolitan area rose 18.9% to 6,746.

The same report attributed the growth in transfer demand to a preference for medical school and to rising numbers of repeat test-takers caused by gaps between early admissions and minimum suneung grade requirements.

It also noted that transfer revenue at the company grew at a 14.7% compound annual rate from 2019 to 2023. News1 reported in June 2026 that expanded quotas at major universities and rising demand for medical and pharmacy transfers are favorable.

Conversely, a shrinking number of vacancies, changes to transfer selection methods, or the elimination of specific admission tracks could weaken demand. Demand in vocational education is diversifying across beauty national licenses, startup and job placement, and art school entrance preparation.

The company points to its large body of admissions data and entrance analysis know-how as its competitive edge. In beauty, the company's stated differentiation is its higher-priced job and startup packages.

Its position as the leader in transfer market share is paired with a gradual shift toward beauty and other businesses. Peers such as MegaStudyEdu and Daekyo offer a reference point, but differences in segment mix limit direct comparison.

06

Outlook

In its March 2026 corporate value-up plan, the company set a target of keeping its shareholder return ratio at 25% or higher through cash dividends from 2026 and achieving a total shareholder return (TSR) of at least 10% per year on average. The same plan targets an EBITDA margin improvement to a range of 28% to 30%.

That metric is calculated differently from operating margin, so the two are not directly comparable. The company cites deeper transfer-admissions content for top-tier medical and pharmacy programs, and an expanded range of higher-priced job and startup packages in beauty education, as growth drivers.

The plan also includes amending the articles of incorporation to make quarterly dividends more predictable.

The fiscal 2025 year-end dividend of KRW 13.0 billion is planned to draw on about KRW 20.5 billion of non-taxable dividend funds secured through a capital reserve reduction, and the company said it plans a fiscal 2026 year-end dividend as well.

A Korea IR Council estimate in a June 2026 article put 2026 sales at KRW 129.0 billion, up 7.9%, and operating profit at KRW 22.9 billion, up 20.2%. The same estimate put beauty revenue at KRW 23.2 billion (up 36.8%) and transfer education revenue at KRW 85.2 billion (up 5.1%).

A report published in August 2026 said beauty revenue rose 33.2% in the first half. The gap between these estimates and cumulative results through the third quarter of 2026 is the next point to track. Whether other businesses sustain their improvement in profitability is another key variable for the outlook.

07

Valuation

PER
6.0×
PBR
1.5×
ROE
24.1%
EPS
₩369
BPS
₩1,476
Dividend per share
₩300

Valuation can be read along two axes: earnings and net asset value. On earnings, profit attributable to controlling shareholders over the latest four quarters totaled KRW 16 billion, and because quarterly profit swings widely, the range of interpretation for earnings multiples is also wide.

Quarterly figures such as KRW 7.41 million in the first quarter of 2026 versus KRW 7.68 billion in the third quarter show that the same share price can imply very different multiples depending on the quarter.

On net asset value, market capitalization sits above total equity of KRW 70.9 billion at year-end 2025, which means the stock trades at a premium to book value. The fiscal 2025 dividend payout ratio was disclosed at 62.8%, and the company said it qualifies as a high-dividend company.

However, a large share of dividend funding comes from capital reserve reductions, and that is a precondition for interpreting dividend sustainability. Comparisons with same-industry peers are limited because segment mixes differ.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Stable earnings from a market-leading transfer franchise

The Kimyoung Pyeonip brand, reported as holding the number one share of the university transfer market, anchors a large part of sales. Transfer education revenue is estimated to rise from KRW 81.1 billion in 2025 to KRW 85.2 billion in 2026.

LS Securities pointed to a 14.7% compound annual growth rate in transfer revenue from 2019 to 2023, and expanding quotas and medical and pharmacy demand are viewed as favorable for the segment.

Beauty expansion and narrowing losses in other businesses

A Korea IR Council estimate put beauty vocational education revenue at KRW 23.2 billion in 2026, up 36.8% from KRW 17.0 billion in 2025. The company said beauty revenue grew 33.2% in the first half of 2026.

The operating loss in other businesses narrowed to KRW 190 million in the first half from KRW 770 million a year earlier, and the simultaneous improvement in both segments is cited as a bullish factor.

Shareholder return policy and dividend commitments

The company set a target of keeping its shareholder return ratio at 25% or higher from 2026, alongside an average annual TSR of at least 10%. It planned a KRW 13.0 billion dividend for fiscal 2025, with a disclosed payout ratio of 62.8%. The company cites its qualification as a high-dividend company as the basis for its dividend policy.

09

Bear factors

Volatile quarterly profit

Operating profit in the first quarter of 2026 was KRW 347 million, the low point of the recent cycle. In the third quarter, sales rose 4.2% year on year to KRW 37.5 billion, but operating profit fell 3.5% to KRW 9.39 billion.

Profit attributable to controlling shareholders over the latest four quarters totaled KRW 16 billion, and quarterly swings remain large.

Transfer demand and admissions rule changes

News1 noted that a shrinking number of vacancies, changes to selection methods or the removal of specific tracks could weaken transfer demand. Because transfer education is the core of revenue, these variables feed directly into results.

Whether the preference for medical school and the growth in repeat test-takers will persist also remains uncertain.

Uncertain profit contribution from beauty and other businesses

News1 cited whether growth in vocational education revenue will translate into real company profit as a risk factor. Other businesses still posted an operating loss of KRW 190 million in the first half of 2026 and have not yet reached profitability. Revenue in that segment fell to KRW 9.85 billion from KRW 11.32 billion a year earlier.

10

Risk factors

Admissions and policy risk

Transfer demand shifts with university quotas and selection formats. If vacancies shrink or selection methods change, growth in transfer revenue could slow. Based on the 2024 LS Securities mix, which put transfer at about 75% of sales, the impact of this risk would be large.

Portfolio profit contribution risk

If expansion in beauty and other businesses does not flow through to consolidated operating profit, the pace of margin improvement could slow. As the first-quarter 2026 operating profit of KRW 347 million shows, seasonality and the cost structure of education cause large swings in quarterly profit. The EBITDA margin target of 28% to 30% remains a plan-stage objective.

Dividend funding and policy risk

A significant share of dividend funding comes from capital reserve reductions, so how dividends link to earnings is itself a risk factor. The company said it plans to use further capital reserve reductions as non-taxable dividend funds after 2026. How dividend size would adjust in a period of falling earnings is not determined by the current policy alone.

11

What to watch next

  1. Late February 2027 (approx.)

    Preliminary fourth-quarter and full-year 2026 results. Timing is based on the prior year's annual disclosure on February 25, 2026. The gap between full-year sales and operating profit and the Korea IR Council estimates (KRW 129.0 billion and KRW 22.9 billion) is the point to track.

  2. By March 31, 2027

    Filing of the 2026 annual business report. Audited full-year figures and the size of the fiscal 2026 year-end dividend will be set in this filing. Progress toward the 25% or higher shareholder return target can be checked here.

  3. Around the March 2027 annual general meeting

    Agenda items at the annual general meeting, including whether the articles of incorporation are amended for quarterly dividends. The 2026 meeting was held on March 25, 2026. Any further capital reserve reduction and the composition of dividend funding will become visible around this time.

  4. Mid-May 2027 (approx.)

    First-quarter 2027 results. Timing is based on the first-quarter 2026 release on May 14, 2026. Whether operating profit stays positive in this seasonally weak quarter and whether beauty revenue growth continues are the points to track.

12

Overall view

Ibkimyoung grew sales from KRW 86.5 billion in 2022 to KRW 119.5 billion in 2025 and operating profit from KRW 3.08 billion to KRW 19.1 billion, lifting operating margin from 3.6% to 16.0% and lowering its debt ratio from 112.1% to 70.4%.

In 2026, beauty revenue grew and the operating loss in other businesses narrowed, yet quarterly operating profit ranged widely from KRW 347 million to KRW 9.39 billion.

The transfer market has supportive factors in larger university quotas and medical and pharmacy demand, alongside weakening factors such as shrinking vacancies and changes to selection methods.

The 25% or higher shareholder return target and the planned KRW 13.0 billion fiscal 2025 dividend show the direction of dividend policy, but a large share of funding relies on capital reserve reductions.

The next checkpoints are preliminary fourth-quarter and full-year 2026 results, the 2026 annual business report, and first-quarter 2027 results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. news.nate.com
  2. news.nate.com
  3. m.news.nate.com
  4. seoul.co.kr
  5. m.news.nate.com
  6. seoul.co.kr
  7. app.rndcircle.io
  8. infostockdaily.co.kr
  9. marketin.edaily.co.kr
  10. edaily.co.kr
  11. thinkpool.com
  12. m.irgo.co.kr
  13. judal.co.kr
  14. judal.co.kr
  15. google.com
  16. jobkorea.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.